Logo

American Heart Association

  16
  0


Final ID: MP479

Intra-Procedural Cardiac Arrest in Patients Undergoing Percutaneous Coronary Intervention: A Comparative Outcomes Analysis Using a Large Scale Health Research Network

Abstract Body (Do not enter title and authors here): Background
Intra-procedural cardiac arrest (IPCA) during percutaneous coronary intervention (PCI) is a rare but life-threatening complication. This study aims to compare outcomes in patients experiencing IPCA during PCI versus those undergoing PCI without cardiac
arrest.

Methods
We conducted a retrospective cohort analysis using the TriNetX global federated health research network, incorporating data from 103 healthcare organizations (2015-2025). Two cohorts were identified: Cohort 1 (PCI with IPCA; n = 3,619) and Cohort 2 (PCI without IPCA; n = 238,091). Propensity score matching (PSM) was applied to balance baseline characteristics (n = 3,861 per cohort). Outcomes were analyzed over a 30-day follow-up period and included in-hospital mortality, myocardial infarction (MI) and heart failure (HF), stroke/transient ischemic attack (TIA), and neurological complications(Anoxic brain damage, intraoperative or postprocedural nervous system complications, or mild cognitive impairment of uncertain etiology.

Results
Patients experiencing IPCA had significantly higher 30-day mortality (24.0% vs. 1.8%; p < 0.001; OR = 17.57, 95% CI: 13.67–22.59). They were at increased risk for MI/HF (17.5% vs. 6.6%; p < 0.001; OR = 2.98, 95% CI: 2.56–3.47), stroke/TIA (4.7% vs. 1.5%; p < 0.001; OR = 3.26, 95% CI: 2.42–4.40), and neurological complications (8.6% vs. 0.3%; p < 0.001; OR = 36.11, 95% CI: 19.22–67.85). Kaplan-Meier survival analysis showed significantly reduced survival probability in the IPCA group (p< 0.001).

Conclusion
IPCA during PCI is associated with markedly increased short-term mortality and adverse cardiovascular and neurological outcomes. These findings highlight the need for early recognition, prompt resuscitative measures, and post-arrest care strategies to improve survival and neurological recovery in this high-risk population.
  • Qadeer, Abdul  ( University of Texas Medical Branch , Galveston , Texas , United States )
  • Pathak, Prutha  ( North Alabama Medical Center , Muscle Shoals , Alabama , United States )
  • Zain, Sarmad  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Bukhari, Syed Muhammad Awais  ( University Hospital Cleveland Cilinc , Cleveland , Ohio , United States )
  • Patel, Siddharth  ( Decatur Morgan Hospital , Muscle Shoals , Alabama , United States )
  • Author Disclosures:
    Abdul Qadeer: DO NOT have relevant financial relationships | Prutha Pathak: DO NOT have relevant financial relationships | Sarmad Zain: DO NOT have relevant financial relationships | Syed Muhammad Awais Bukhari: DO NOT have relevant financial relationships | Siddharth Patel: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cracking the Code of Coronary Care: Timing, Trials, and Turning Points in Acute MI Management

Saturday, 11/08/2025 , 10:45AM - 11:55AM

Moderated Digital Poster Session

More abstracts from these authors:
Association Between Elevated Lipoprotein(a) and New-Onset Atrial Fibrillation: A Retrospective Analysis Using the TriNetX Research Network

Qadeer Abdul, Akbar Usman, Ahmed Faizan, Shabbir Muhammad Raffey, Aamir Muhammad, Fouad Michele, Khan Allahdad, Khawar Muneeb, Pathak Prutha, Hassan Furqan, Hotwani Priya, Khan Sardar Muhammad Imran, Shafique Nouman

Efficacy of Mavacamten Combined with Standard Therapy in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Qadeer Abdul, Shehryar Muhammad, Malik Muhammad Jehangir Ameen, Usman Muhammad, Khan Sardar Muhammad Imran, Hamza Mohammad, Fouad Michele, Khawar Muneeb, Pathak Prutha, Nadeem Ali Ahmad, Muhammad Awon, Hadeed Khawar Mirza Muhammad, Bista Roshani, Twayana Anu

You have to be authorized to contact abstract author. Please, Login
Not Available